Role of Vaskadikwath in Non Proliferative Diabetic Retinopathy

To Study the Efficacy of Vaskadikwath in Pramehjanya Timir with special Reference to Non Proliferative Diabetic Retinopathy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/051044

Enrollment

Registered

2023-03-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes Health Condition 2: H350- Background retinopathy and retinalvascular changes Health Condition 3: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients type2 Non Insulin Dependent Diabetes with or without visual disturbance but detectable opthalmosope features of Diabetic Retinopathy with blood level FBS 126 to 220mg/dl or PPBS 170 to 330mg/dl with ongoing treatment Early stage of NPDR

Exclusion criteria

Exclusion criteria: Patients who are extremely debilitating and those who are not withstand treatment procedure High risk Diabetic Retinopathy or those requiring emergency intervention Patients of Diabetic Retinopathy with media opacities like cataract vitreous degeneration etc with interfere with opthalmosopical finding Patients having other ocular like glaucoma High myopia Hypertensive Retinopathy and Diabetic Retinopathy associated with pregnancy Patients who BCVA is less than 6/60

Design outcomes

Primary

Measure	Time frame
Improvement of visionTimepoint: 60days	—

Secondary

Measure	Time frame
Improvement of vision Timepoint: 30days	—

Countries

India

Contacts

Public ContactDr Prof Kumari Uma Pandey

Government Ayurvedic College Patna

dr.kumariuma@yahoo.co.in8002951964

Outcome results